{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:45:56Z","timestamp":1793303156570,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171834"],"award-info":[{"award-number":["82171834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32301169"],"award-info":[{"award-number":["32301169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32171382"],"award-info":[{"award-number":["32171382"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32471443"],"award-info":[{"award-number":["32471443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["24KJB310017"],"award-info":[{"award-number":["24KJB310017"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2308085QH281"],"award-info":[{"award-number":["2308085QH281"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013058","name":"Jiangsu Provincial Key Research and Development Program","doi-asserted-by":"publisher","award":["BE2022725"],"award-info":[{"award-number":["BE2022725"]}],"id":[{"id":"10.13039\/501100013058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jconrel.2025.113792","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:14:30Z","timestamp":1745925270000},"page":"113792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Reprogramming of radiation-deteriorated TME by liposomal nanomedicine to potentiate radio-immunotherapy"],"prefix":"10.1016","volume":"383","author":[{"given":"Yue","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yansheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.113792_bb0005","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0010","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0015","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/s43018-022-00467-x","article-title":"Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade","volume":"3","author":"Spurr","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.jconrel.2025.113792_bb0020","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1038\/s41467-024-49482-9","article-title":"Programmable melanoma-targeted radio-immunotherapy via fusogenic liposomes functionalized with multivariate-gated aptamer assemblies","volume":"15","author":"Ren","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2025.113792_bb0025","first-page":"855","article-title":"Radiotherapy-induced metabolic hallmarks in the tumor microenvironment, trends","volume":"8","author":"Mittal","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.113792_bb0030","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.ccell.2023.06.007","article-title":"Tissue factor is a critical regulator of radiation therapy-induced glioblastoma remodeling","volume":"41","author":"Jeon","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2025.113792_bb0035","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113792_bb0040","doi-asserted-by":"crossref","first-page":"eabc6998","DOI":"10.1126\/sciimmunol.abc6998","article-title":"The AIM2 and NLRP3 inflammasomes trigger IL-1\u2013mediated antitumor effects during radiation","volume":"6","author":"Han","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113792_bb0050","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/1078-0432.CCR-08-1471","article-title":"Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors","volume":"15","author":"Chen","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.113792_bb0055","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ijrobp.2021.12.162","article-title":"Radiation therapy promotes hepatocellular carcinoma immune cloaking via PD-L1 upregulation induced by cGAS-STING activation","volume":"112","author":"Du","year":"2022","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2024.10.010","article-title":"Biomaterials to regulate tumor extracellular matrix in immunotherapy","volume":"376","author":"Zhang","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113792_bb0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.gde.2004.12.005","article-title":"Cellular abnormalities of blood vessels as targets in cancer","volume":"15","author":"Baluk","year":"2005","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jconrel.2025.113792_bb0070","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.biotechadv.2016.04.005","article-title":"Hypoxic tumor microenvironment: opportunities to develop targeted therapies","volume":"34","author":"Patel","year":"2016","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2025.113792_bb0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113792_bb0080","doi-asserted-by":"crossref","first-page":"eadg3868","DOI":"10.1126\/sciimmunol.adg3868","article-title":"Cellular and molecular waypoints along the path of T cell exhaustion","volume":"8","author":"Lan","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0085","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3389\/fimmu.2020.01906","article-title":"Hypoxia induces mitochondrial defect that promotes T cell exhaustion in tumor microenvironment through MYC-regulated pathways","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0090","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","article-title":"Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion","volume":"22","author":"Scharping","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13046-021-02000-x","article-title":"Interfering with tumor hypoxia for radiotherapy optimization","volume":"40","author":"Telarovic","year":"2021","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"10.1016\/j.jconrel.2025.113792_bb0100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113792_bb0105","doi-asserted-by":"crossref","first-page":"2312197","DOI":"10.1002\/adfm.202312197","article-title":"Simultaneous modulation of hypoxia and metabolism in glioblastoma for enhanced radio-immunotherapy","volume":"34","author":"Xie","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2025.113792_bb0110","doi-asserted-by":"crossref","first-page":"2309332","DOI":"10.1002\/adma.202309332","article-title":"Nanozyme-coated bacteria hitchhike on CD11b+ immune cells to boost tumor radioimmunotherapy","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113792_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.484","article-title":"Oxygen-driven cuproptosis synergizes with radiotherapy to potentiate tumor immunotherapy","volume":"5","author":"Pei","year":"2024","journal-title":"Aggregate"},{"key":"10.1016\/j.jconrel.2025.113792_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40820-019-0347-0","article-title":"Recent advances in tumor microenvironment hydrogen peroxide-responsive materials for cancer photodynamic therapy","volume":"12","author":"Yang","year":"2020","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.jconrel.2025.113792_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215049","article-title":"Recent advances on modulation of H2O2 in tumor microenvironment for enhanced cancer therapeutic efficacy","volume":"481","author":"Chu","year":"2023","journal-title":"Coordin. Chem. Rev."},{"key":"10.1016\/j.jconrel.2025.113792_bb0130","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1021\/acsnano.9b01087","article-title":"Catalase-integrated hyaluronic acid as nanocarriers for enhanced photodynamic therapy in solid tumor","volume":"13","author":"Phua","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113792_bb0135","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/hsz-2017-0131","article-title":"Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach","volume":"398","author":"Glorieux","year":"2017","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jconrel.2025.113792_bb0140","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2147\/IJN.S359156","article-title":"Combined Prussian blue nanozyme carriers improve photodynamic therapy and effective interruption of tumor metastasis","volume":"17","author":"Shen","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2025.113792_bb0145","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2022.04.029","article-title":"131I-\u03b1PD-L1 immobilized by bacterial cellulose for enhanced radio-immunotherapy of cancer","volume":"346","author":"Qi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.113792_bb0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41573-021-00345-8","article-title":"The foundations of immune checkpoint blockade and the ipilimumab approval decennial","volume":"21","author":"Korman","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113792_bb0155","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.3390\/cancers13081922","article-title":"Anti-PD-1\/PD-L1 based combination immunotherapy to boost antigen-specific CD8+ T cell response in hepatocellular carcinoma","volume":"13","author":"Pe\u00f1a-Asensio","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2025.113792_bb0160","doi-asserted-by":"crossref","first-page":"eabl9330","DOI":"10.1126\/sciimmunol.abl9330","article-title":"ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer","volume":"7","author":"Hsieh","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0165","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2017.12.001","article-title":"RAS and PD-L1: a masters' liaison in Cancer immune evasion","volume":"47","author":"Glodde","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113792_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.964442","article-title":"The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers","volume":"13","author":"Tang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0175","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41586-024-07121-9","article-title":"Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells","volume":"627","author":"Guan","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113792_bb0180","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/d41573-022-00030-4","article-title":"Challenges and opportunities in the PD1\/PDL1 inhibitor clinical trial landscape","volume":"21","author":"Upadhaya","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2025.113792_bb0185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2025.113792_bb0190","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3389\/fphar.2020.00441","article-title":"Resistance to PD-L1\/PD-1 blockade immunotherapy. A tumor-intrinsic or tumor-extrinsic phenomenon?","volume":"11","author":"Chocarro de Erauso","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0195","doi-asserted-by":"crossref","first-page":"2303175","DOI":"10.1002\/advs.202303175","article-title":"Challenges coexist with opportunities: spatial heterogeneity expression of PD-L1 in cancer therapy","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.113792_bb0200","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.molcel.2019.04.005","article-title":"PD-L1 (B7-H1) competes with the RNA exosome to regulate the DNA damage response and can be targeted to sensitize to radiation or chemotherapy","volume":"74","author":"Tu","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jconrel.2025.113792_bb0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-021-00431-4","article-title":"Programmed death ligand 1 signals in cancer cells","volume":"22","author":"Kornepati","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.113792_bb0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral Tcf1+PD-1+CD8+ T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2025.113792_bb0215","doi-asserted-by":"crossref","first-page":"eabj9123","DOI":"10.1126\/sciimmunol.abj9123","article-title":"Tumor microenvironmental signals reshape chromatin landscapes to limit the functional potential of exhausted T cells","volume":"7","author":"Ford","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0220","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41590-023-01624-9","article-title":"Cancer- and infection-induced T cell exhaustion are distinct","volume":"24","author":"Buck","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.113792_bb0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41586-022-05257-0","article-title":"PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program","volume":"610","author":"Hashimoto","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2025.113792_bb0230","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1073\/pnas.0801497105","article-title":"Selective expansion of a subset of exhausted CD8 T cells by \u03b1PD-L1 blockade","volume":"105","author":"Blackburn","year":"2008","journal-title":"P. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.113792_bb0235","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1021\/acsnano.9b00661","article-title":"Ligand-modified cell membrane enables the targeted delivery of drug nanocrystals to glioma","volume":"13","author":"Chai","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.113792_bb0240","doi-asserted-by":"crossref","first-page":"1700141","DOI":"10.1002\/adma.201700141","article-title":"ROS-responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy","volume":"29","author":"Xu","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.113792_bb0245","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.celrep.2016.08.032","article-title":"BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression","volume":"16","author":"Zhu","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2025.113792_bb0250","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.celrep.2017.02.011","article-title":"BET-bromodomain inhibitors engage the host immune system and regulate expression of the immune checkpoint ligand PD-L1","volume":"18","author":"Hogg","year":"2017","journal-title":"Cell Rep."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925004122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:45:01Z","timestamp":1777509901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925004122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":50,"alternative-id":["S0168365925004122"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113792","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming of radiation-deteriorated TME by liposomal nanomedicine to potentiate radio-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.113792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113792"}}